| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5275220
Max Phase: Preclinical
Molecular Formula: C11H21N5O2
Molecular Weight: 255.32
Associated Items:
Representations
Canonical SMILES: CCCC[C@H](CCO)Nc1nc(N)nnc1OC
Standard InChI: InChI=1S/C11H21N5O2/c1-3-4-5-8(6-7-17)13-9-10(18-2)15-16-11(12)14-9/h8,17H,3-7H2,1-2H3,(H3,12,13,14,16)/t8-/m1/s1
Standard InChI Key: UYAIFZYFIXJEDE-MRVPVSSYSA-N
Associated Targets(Human)
Toll-like receptor 8 1853 Activities
Toll-like receptor 7 2626 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 255.32 | Molecular Weight (Monoisotopic): 255.1695 | AlogP: 0.82 | #Rotatable Bonds: 8 |
| Polar Surface Area: 106.18 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 4.96 | CX LogP: 0.62 | CX LogD: 0.62 |
| Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.63 | Np Likeness Score: -0.15 |
References
| 1. Kaushik D, Kaur A, Petrovsky N, Salunke DB.. (2021) Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles., 12 (7.0): [PMID:34355178] [10.1039/D1MD00031D] |
Source
Source(1):